E-DRUG: Webinar June 29 - Effectiveness and limitations of compulsory licenses to promote access to medicines
---------------------------------------------------------------------------
Dear all,
We are happy to invite you to the next webinar of the Knowledge Network for
Innovation and Access to Medicines, a project of the Global Health Centre,
Graduate Institute of Geneva.
For those who can't join live, the recording will be made available at
https://www.knowledgeportalia.org/webinars.
Effectiveness and limitations of compulsory licenses to promote access to
medicines
Tuesday, June 29, 4pm - 5pm CET
To join the webinar, please register here:
https://us02web.zoom.us/webinar/register/9416239278084/WN_2k3Qddt8QNeHU1cAzWMdQw
Speakers:
Eduardo Urias, Assistant Professor, Faculty of Science, Athena Institute,
VU University Amsterdam
Danielle Navarro, Research Assistant, Global Health Centre, Graduate
Institute of Geneva
Research:
Urias, Eduardo, and Shyama V. Ramani. 2020.'Access to Medicines after
TRIPS: Is Compulsory Licensing an Effective Mechanism to Lower Drug Prices?
A Review of the Existing Evidence.' Journal of International Business
Policy 3 (4): 367-84.
https://doi.org/10.1057/s42214-020-00068-4.
Navarro, Danielle, Marcela Vieira, Suerie Moon, Adrian Alonso Ruiz, and
Anna Bezruki. 2021. 'Research Synthesis: Compulsory Licensing'. Knowledge
Portal on Innovation and Access to Medicines, Global Health Centre,
Graduate Institute of International and Development Studies, Geneva.
https://www.knowledgeportalia.org/compulsory-licensing.
Intellectual property and other market rights can limit the availability
and accessibility of protected health technologies as they grant
exclusivity of manufacturing and commercialization. There are measures that
can be used to allow for production and/or importation from a broader range
of producers, such as compulsory licenses. It has been, and remains, a
contentious topic, as still seen today regarding its use in the context of
the COVID-19 pandemic. Eduardo Urias will discuss the findings of a recent
study analysing the evidence on the impact of compulsory licensing on drug
prices and options to address some of its limitations, such as procedural
refinements to ease its implementation and the development of technological
and manufacturing capabilities in developing countries. Danielle Navarro
will present a synthesis of the available literature on the effects of
compulsory licenses and identified limitations and challenges regarding its
implementation.
The webinar is free and open to the public and will be held in English.
Participants can pose questions orally or in writing, and the speakers will
respond to a selection of these during the second half of the event.
Recordings of all webinars are made available at the Knowledge Portal on
Innovation and Access to Medicines. After registering, you will receive a
confirmation email with additional information on how to join the webinar
using the Zoom platform. This event is part of the webinar series of the
Knowledge Network for Innovation and Access to Medicines, Global Health
Centre, Graduate Institute of Geneva.
Marcela Vieira <marcelacfvieira@gmail.com>